galectin-3
Showing 1 - 25 of >10,000
Galectin-3 in Serum and Saliva of Pemphigus Patients
Not yet recruiting
- Galectin-3 and Pemphigus
- Galectin 3 measurement in serum and saliva by ELIZA
- (no location specified)
Aug 8, 2023
Serum Galectin-3 as a Marker of Human Papillomavirus Infection
Completed
- Human Papillomavirus Infection
- cryotherapy
- serum Galectin-3 assay
-
Assiut, EgyptAssiut University
Aug 17, 2023
Placenta Accreta Spectrum Pregnancies
Completed
- Placenta Accreta, Third Trimester
- Galectin 3
-
Konya, TurkeyNecmettin Erbakan University Meram Medicine Faculty
Jul 6, 2023
Galectin-3 in Papillary Thyroid Carcinoma
Not yet recruiting
- Galactin 3-thyroid Carcinoma
- (no location specified)
Jan 26, 2023
Galectin-3 and Placenta Accreta
Completed
- Placenta Accreta
- Galectin-3
- Placental Galactin-3
-
Assiut, EgyptWomen Health Hospital - Assiut university
Oct 7, 2022
Acute Kidney Injury, Sepsis Trial in Foshan (Standard Reagents, Whole Blood)
Recruiting
- Acute Kidney Injury
- Sepsis
- Standard Reagents, Whole Blood
-
Foshan, ChinaCritical Care Department, First People's Hospital of Foshan
Jan 19, 2023
Thyroglobulin and Galectin-3 for Prognosis and Follow-up in
Recruiting
- Thyroid Cancer
- +2 more
-
Taipei, TaiwanChih-Yuan Wang, M.D
Oct 16, 2022
GCF Galectin-3 and Interleukin-1beta Levels in Periodontitis.
Completed
- Periodontitis
- Periodontal Inflammation
- Periodontal clinical measurements and gingival crevicular fluid sampling
-
Aydın, TurkeyAdnan Menderes University, Faculty of Dentistry, Department of P
Jul 4, 2022
Galectin and Respiratory Weaning
Recruiting
- Galectin-3 During Respiratory Weaning
- Labaratory tests
-
Nidda, GermanyNeurologische Klinik Bad Salzhausen
Feb 15, 2022
GCF And Salivad of Patients With Different Periodontal Diseases
Recruiting
- Periodontal Diseases
- GCF obtaining
- saliva obtaining
-
Cairo, EgyptCairo university Faculty of dentistry
Mar 15, 2022
s of Galectin-3, Soluble ST2 and BNP in Predicting Clinical
Not yet recruiting
- ST Elevation Myocardial Infarction
- +2 more
- (no location specified)
Feb 17, 2022
Thyroid Cancer Trial in Taipei
Active, not recruiting
- Thyroid Cancer
-
Taipei, Taipei City, TaiwanNational Taiwan University Hospital
Nov 14, 2021
Gingivitis, Periodontitis Trial in Fayoum (GCF sample collection, non-surgical periodontal treatment)
Active, not recruiting
- Gingivitis
- Periodontitis
- GCF sample collection
- non-surgical periodontal treatment
-
Fayoum, Egyptfaculty of dentistry, Fayoum university
Sep 14, 2023
Galectin-3 Level in Ankylosing Spondylitis Patients
Completed
- Ankylosing Spondylitis
- Serum galectin-3 concentration was measured.
- (no location specified)
Apr 17, 2021
Metastatic Melanoma, Head and Neck Squamous Cell Carcinoma Trial in Portland (GB1211, Pembrolizumab, Placebo)
Not yet recruiting
- Metastatic Melanoma
- Head and Neck Squamous Cell Carcinoma
- GB1211
- +2 more
-
Portland, OregonProvidence Portland Medical Center
Jun 19, 2023
Periodontitis and Coronary Heart Disease on Galectin-3
Completed
- Periodontal Diseases
- Observation of serum and salivary Galectin-3 levels
-
Messina, ItalyUniversity of Messina
Dec 18, 2020
Hypertension Trial in Boston (Modified Citrus Pectin (MCP) vs )
Completed
- Hypertension
- Modified Citrus Pectin (MCP) vs placebo
-
Boston, MassachusettsMassachusetts General Hospital
Feb 17, 2021
Periodontal Diseases Trial in Izmir (GCF obtaining)
Completed
- Periodontal Diseases
- GCF obtaining
-
İzmir, TurkeyIzmir Katip Çelebi University Department of Periodontology
Mar 1, 2021
Idiopathic Pulmonary Fibrosis Trial in United Kingdom (Inhaled TD139, Placebo)
Completed
- Idiopathic Pulmonary Fibrosis
- Inhaled TD139
- Placebo
-
Exeter, Devon, United Kingdom
- +4 more
Mar 16, 2021
Endometriosis, Endometriosis Ovary, Endometriosis Rectovaginal Septum Trial
Not yet recruiting
- Endometriosis
- +2 more
- (no location specified)
Apr 12, 2021
Adaptive Mechanisms In GRown up ObeSity Study (AMIGROS)
Recruiting
- Obesity
- Type 2 Diabetes
- Subcutaneous microdialysis
-
Gothenburg, Region Vastra Gotaland, SwedenGothia Forum CTC
Sep 26, 2023
Metastatic Melanoma Trial in Portland (1 mg/kg GR-MD-02, 2 mg/kg GR-MD-02, 4 mg/kg GR-MD-02)
Completed
- Metastatic Melanoma
- 1 mg/kg GR-MD-02
- +4 more
-
Portland, OregonProvidence Portland Medical Center
Mar 19, 2019